Opendata, web and dolomites

TheraSonix SIGNED

Ultrasonic Imaging and Drug Propulsion Into Tumors Using Genetically Encoded Gas Nanostructures

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 TheraSonix project word cloud

Explore the words cloud of the TheraSonix project. It provides you a very rough idea of what is the project "TheraSonix" about.

filled    imaging    overcoming    microbubble    collapse    tumors    act    layers    vasculature    limitation    maturity    streaming    cellular    size    agents    microbes    one    constants    few    therapies    mass    attractive    bind    professional    penetration    vesicles    stable    homing    signal    expand    engineering    produces    selectivity    ultrasound    gas    buoyant    therapeutic    nanostructures    genetically    vastly    nanoscale    anticancer    core    time    affordability    combine    utilize    match    tissues    conventional    position    class    therapeutics    photosynthetic    circulation    microbubbles    unlike    propels    energy    encoded    pharmacokinetic    vibration    overcome    drugs    concentrated    phenomenon    modern    dimensions    tumor    limited    waves    local    penetrating    re    hypothesize    deeper    extravasate    times    cell    ultrasonic    gvs    fluid    effect    diversify    inforce    physically    heterogeneous    advancements    bubbles    shortcomings    enhanced    prevents    efficacy    nuclei    cavitation    drug    protein    influence   

Project "TheraSonix" data sheet

The following table provides information about the project.

Coordinator
TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD 

Organization address
address: THE SENATE BUILDING TECHNION CITY 1
city: HAIFA
postcode: 32000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 263˙385 €
 EC max contribution 263˙385 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-GF
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD IL (HAIFA) coordinator 263˙385.00
2    CALIFORNIA INSTITUTE OF TECHNOLOGYCORP US (PASADENA) partner 0.00

Map

 Project objective

One of the important shortcomings of modern anticancer therapies is their limited penetration depth of only a few cell layers into the tumor. Concentrated around the heterogeneous vasculature, these drugs produce only a local therapeutic effect. In this project we propose a method of overcoming this limitation by engineering a novel class of gas-filled nanostructures capable of homing to tumor tissues, and using their vibration in response to ultrasound energy to deliver drugs deeper into the tumor core. The proposed approach is based on ultrasonic cavitation, a phenomenon in which gas bubbles expand and collapse under the influence of ultrasound waves. This process produces fluid streaming that propels drugs deeper into the tumor mass. The use of ultrasound for drug delivery is attractive due to its availability and affordability. However, the use of this technology is currently limited by the properties of conventional microbubble-based cavitation nuclei: their large size prevents them from penetrating into the tumor and their short circulation times do not match the pharmacokinetic time constants of many drugs. To overcome these challenges, we will utilize gas vesicles (GVs), a unique class of genetically encoded, gas-filled protein nanostructures derived from buoyant photosynthetic microbes, as cavitation nuclei. Unlike microbubbles, GVs are physically stable and their nanoscale dimensions have the potential to enable them to extravasate into tumors and bind to specific cellular targets. We hypothesize that GVs can act as both imaging agents and cavitation nuclei. If so, this therapeutic approach could have vastly improved efficacy and selectivity and the potential to combine cavitation-enhanced drug delivery with emerging advancements in cell based therapeutics. This project will enable the applicant to diversify his capabilities and experience beyond ultrasound imaging and signal processing and re-inforce a position of professional maturity.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "THERASONIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "THERASONIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

TxnEvoClim (2019)

Climate adaptation in Arabidopsis thaliana through evolution of transcription regulation

Read More  

PROTEAN (2019)

Prospective Environmental Assessment of Urban Agriculture Emerging-Systems

Read More  

CONDISOBS (2020)

Contain, Distribute, Obstruct. Governing the Mobility of Asylum Seekers in the European Union

Read More